At BiRDS Pharma AG, the drug development projects are taken at fast track to a development stage that allows for partnering with the pharmaceutical industry. BiRDS Pharma AG primarily seeks licensees or cooperation partners to take the projects to a later stage of development. The ultimate goal of each drug development drug development project is the Dossier for Application for Marketing Authorization, where partnering with large globally active pharmaceutical companies is envisaged for product marketing. At earlier stages, which range from preclinical proof-of-concept to first-time-in-man results, BiRDS Pharma AG actively enters into development collaborations with smaller or regional pharmaceutical companies to help taking the projects to a stage that will allow for global partnering, typically after clinical Phase II or Phase III. Development collaborations will typically be based on shareholding to avoid conflicts of interest and to assure returns based on contribution. |
